Christopher Giordano is President and Chief Executive Officer of TENAX THERAPEUTICS, INC. (TENX). The company reported total compensation of $8,079,633 for fiscal year 2025.
| Salary | $563,734 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $7,266,000 |
| Non-equity incentive plan | $204,375 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $45,524 |
| Total | $8,079,633 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure TENAX THERAPEUTICS, INC. filed April 22, 2026, accession 0001193125-26-168580.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Christopher Giordano this page | President and Chief Executive Officer | $8,079,633 |
| Stuart Rich | Chief Medical Officer | $3,732,967 |
| Thomas McGauley | Interim Chief Financial Officer | $475,498 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full TENAX THERAPEUTICS, INC. compensation brief.
Christopher Giordano's compensation sits inside TENAX THERAPEUTICS, INC.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.